Literature DB >> 11045670

Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains.

S Kato1, T Shinozawa, M Takikawa, M Kato, A Hirano, A Awaya, E Ohama.   

Abstract

The glial cytoplasmic inclusion (GCI) is a histological hallmark for multiple system atrophy (MSA): these inclusions are found in oligodendrocytes and consist of abnormal granule-coated fibrils of approximately 24- to 40-nm diameter. To clarify the significance of the presence of midkine (MK) in these GCIs, we carried out immunohistochemical, electron and immunoelectron microscopical, and Western blot analyses of MSA brains using a monoclonal antibody against the C-terminal region of human MK. Immunohistochemically, most of the GCIs were intensely stained by the antibody to MK. Electron and immunoelectron microscopy showed that the GCIs were composed of MK-positive granule-coated fibrils that were essential constituents of these inclusions. No significant MK immunoreactivity was observed in oligodendrocytes, astrocytes and neurons of the normal control subjects. The presence of MK in MSA brain but not in normal brain was confirmed by Western blotting. Together with the fact that MK is associated with fetal morphogenesis during the midgestation period, the presence of MK immunoreactivity in oligodendroglial GCIs may suggest the existence of a repair mechanism on the basis of morphogenesis in the degenerated oligodendrocytes themselves as well as the affected neurons and their axons through the oligodendrocyte-axon-neuron relationship.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045670     DOI: 10.1007/s004010000214

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  9 in total

Review 1.  Multiple system atrophy: cellular and molecular pathology.

Authors:  D J Burn; E Jaros
Journal:  Mol Pathol       Date:  2001-12

2.  The advances of Midkine with peripheral invasion in pancreatic cancer.

Authors:  Jun Yao; Wen-Yao Li; She-Gan Gao
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

Review 3.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 4.  Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Authors:  Benjamin Ettle; Johannes C M Schlachetzki; Jürgen Winkler
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

Review 5.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

Review 6.  Midkine in repair of the injured nervous system.

Authors:  Yoshihiro Yoshida; Harutoshi Sakakima; Fumiyo Matsuda; Masako Ikutomo
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 7.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.

Authors:  Seiji Kaji; Takakuni Maki; Tomoyuki Ishimoto; Hodaka Yamakado; Ryosuke Takahashi
Journal:  Transl Neurodegener       Date:  2020-02-17       Impact factor: 8.014

9.  Role of VAPB and vesicular profiles in α-synuclein aggregates in multiple system atrophy.

Authors:  Fumiaki Mori; Yasuo Miki; Kunikazu Tanji; Tomoya Kon; Masahiko Tomiyama; Akiyoshi Kakita; Koichi Wakabayashi
Journal:  Brain Pathol       Date:  2021-07-01       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.